Singapore’s highly restrictive laws governing assisted reproduction—specifically the ban on surrogacy, the exclusion of same-sex couples from accessing fertility treatments, and strict limits on the number of donor offspring—will severely stifle any return on investment in IVG technology.
Singapore should not Invest in Research and Development (R&D) of In Vitro Gametogenesis (IVG) Technology for Human Clinical Assisted Reproduction
Alexis Heng Boon Chin
